Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJun 2, 2021Rectiv (nitroglycerin) Ointment 0.4% For Intra-anal Use Only 30 gCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0419-2021Class IITerminatedJun 2, 2021NamzaricCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0418-2021Class IITerminatedJun 2, 2021LinzessCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0417-2021Class IITerminatedJun 2, 2021RESTASIS 0.05%30X 0.4ML OPTH PFCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0416-2021Class IITerminatedJun 2, 2021UBRELVY 100MG 10UD CPLTCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0415-2021Class IITerminatedJun 2, 2021Vaniqa (eflornithine hydrochloride) CreamCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0414-2021Class IITerminatedJun 2, 2021BROMFENAC OPHTHALMIC SOLUTION 0.09% 1.7MLCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0413-2021Class IITerminatedJun 2, 2021Metoprolol Tartrate and Hydrochlorothiazide TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0412-2021Class IITerminatedJun 2, 2021COSOPT (Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution)CGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0411-2021Class IITerminatedJun 2, 2021Atropine Sulfate Ophthalmic SolutionCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0410-2021Class IITerminatedJun 2, 2021LIDOCAINE HCL VISC 2% 100MLCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0409-2021Class IITerminatedJun 2, 2021OFLOXACIN 0.3% 5ML OPTHCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0408-2021Class IITerminatedJun 2, 2021FENOFIBRATE CAPSULESCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0407-2021Class IITerminatedJun 2, 2021METHOCARBAMOL 500MG 500CGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0406-2021Class IITerminatedJun 2, 2021SynthroidCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0405-2021Class IITerminatedJun 2, 2021Norvir Ritonavir Tablets 100 mg 30 TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0404-2021Class IITerminatedJun 2, 2021Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodiumCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0403-2021Class IITerminatedJun 2, 2021Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36CGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0402-2021Class IITerminatedJun 2, 2021NIACIN 250MG 110CGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0401-2021Class IITerminatedJun 2, 2021THERAPEUTIC M 130CGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0400-2021Class ITerminatedJun 2, 2021NP Thyroid 120 Thyroid TabletsSubpotent DrugAcella Pharmaceuticals, LLC · D-0399-2021Class ITerminatedJun 2, 2021NP Thyroid 90 Thyroid TabletsSubpotent DrugAcella Pharmaceuticals, LLC · D-0398-2021Class ITerminatedJun 2, 2021NP Thyroid 60 Thyroid TabletsSubpotent DrugAcella Pharmaceuticals, LLC · D-0397-2021Class ITerminatedJun 2, 2021NP Thyroid 30 Thyroid TabletsSubpotent DrugAcella Pharmaceuticals, LLC · D-0396-2021Class ITerminatedJun 2, 2021NP Thyroid 15 Thyroid TabletsSubpotent DrugAcella Pharmaceuticals, LLC · D-0395-2021Class IIOngoingJun 2, 2021DaytranaDefective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.Noven Pharmaceuticals Inc · D-0394-2021Class IIOngoingJun 2, 2021DaytranaDefective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.Noven Pharmaceuticals Inc · D-0393-2021Class IIITerminatedJun 2, 2021Olmesartan Medoxomil TabletsPresence of Foreign Tablet/CapsuleAscend Laboratories LLC · D-0392-2021Class IIITerminatedMay 26, 2021Cequa (cyclosporine ophthalmic solution) 0.09%Subpotent and Presence of Particulates .Sun Pharmaceutical Industries Inc · D-0391-2021Class IITerminatedMay 26, 2021Cefixime for Oral Suspension USP 100 mg/5mLSubpotent DrugLupin Pharmaceuticals Inc. · D-0390-2021Class IITerminatedMay 26, 2021Delflex Peritoneal Dialysis Solution with 1.5% DextroseLabeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box.Fresenius Medical Care, North America · D-0389-2021Class IITerminatedMay 26, 2021Thumbs Up 7 Blue 69KMarketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.Bit & Bet LLC · D-0388-2021Class IIITerminatedMay 26, 2021Dry Eye TestSubpotent DrugNomax Inc · D-0387-2021Class IIITerminatedMay 26, 2021Hydrocodone Bitartrate and Homatropine Methlybromide tabletsFailed Impurities/Degradation SpecificationsKVK-Tech, Inc. · D-0386-2021Class IIOngoingMay 26, 2021Preferred Pharmaceuticals IncCMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.Preferred Pharmaceuticals, Inc. · D-0385-2021Class IITerminatedMay 26, 2021Sterile Water for InjPresence of Particulate Matter: particulate matter identified as an insect in one vial.Pfizer Inc. · D-0384-2021Class IIOngoingMay 26, 2021Triple SupremeZen Plus 3500Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.Hyobin LLC · D-0383-2021Class IIOngoingMay 26, 2021PremierZen Black 5000Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.Hyobin LLC · D-0382-2021Class IIOngoingMay 26, 2021PremierZen Extreme 3000Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.Hyobin LLC · D-0381-2021Class IIITerminatedMay 26, 2021Asenapine Sublingual TabletsIncorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agentSigmaPharm Laboratories LLC · D-0380-2021

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.